Press-release for stocks related to research for ONCY

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K

| -19.71% | O: 2.92% H: 0.0% C: -0.71%
biotech positive sabcs

Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published: 2023-10-20 (Crawled : 14:30) - prnewswire.com
SGEN | $228.74 0.1% 20M

| 6.41% | O: 0.15% H: 0.0% C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K

| -32.1% | O: -1.85% H: 3.14% C: -2.52%
MYGN | $18.75 0.81% 150K

| 26.88% | O: 0.41% H: 3.13% C: 2.38%
ILMN | $122.25 -1.78% 400K

| 3.73% | O: 0.02% H: 0.94% C: -0.3%
BNTX | News | $88.185 -0.35% 140K

| -5.09% | O: -1.46% H: 0.48% C: -1.06%
companies biotech cancer pancreatic treatment research

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
Published: 2023-06-08 (Crawled : 22:00) - biospace.com/
GSK | News | $40.905 -0.81% 890K

| 20.02% | O: 0.41% H: 0.68% C: 0.64%
PGEN | $1.405 0.36% 320K

| 6.06% | O: 0.0% H: 0.76% C: -4.55%
ONCY | $1.045 -3.24% -3.35% 180K

| -30.82% | O: 0.63% H: 1.87% C: -1.25%
ITOS | $10.8 -1.73% 50K

| -29.23% | O: -0.52% H: 3.23% C: -2.2%
GILD | $66.99 -0.06% 3.3M

| -11.9% | O: -0.42% H: 3.56% C: 3.48%
cancer

Oncolytics Biotech® Achieves Success Criteria for Efficacy in the Pancreatic Cancer Cohort of GOBLET
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K

| 5.77% | O: -1.92% H: 2.35% C: -2.7%
biotech success cancer pancreatic

| -39.89% | O: 2.73% H: 0.0% C: -5.85%
biotech chinese treatment trial cancer iot breast cancer

Oncolytics Biotech® Releases a Letter to Shareholders - 2021 Review and 2022 Outlook
Published: 2022-01-11 (Crawled : 13:30) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K

| -17.29% | O: 1.88% H: 0.0% C: 0.0%

| -48.6% | O: 1.4% H: 0.49% C: -1.84%
phase 1 test cancer biotech gastrointestinal iot